New Generation Spectral Computed Tomography and Nano Contrast Media for Osteoarthritis Diagnosis

Description of the granted funding

Spectral computed tomography represents the future of X-ray imaging. Commercial instrumentation is not yet available in Finland. The technology allows retrospective detection of individual elements with only one scan, making it a superb modality to simultaneously trace multiple contrast agents. Concurrently, modern nanotechnology enables more effective design of active targeting contrast agents. The project develops a spectral computed tomography method for early diagnosis of articular cartilage injuries based on the simultaneous use of separate nano contrast agents. The solution to be developed will enable lower radiation doses in imaging, improved imaging accuracy, as well as new information for the optimization of future spectral imaging and nano contrast agents. Achieving these goals is greatly facilitated by active international collaboration and research exchange with the top groups in distinguished research institutes.
Show more

Starting year

2023

End year

2027

Granted funding

Janne Mäkelä Orcid -palvelun logo
447 650 €

Funder

Research Council of Finland

Funding instrument

Academy research fellows

Other information

Funding decision number

348410

Fields of science

Medical engineering

Research fields

Lääketieteellinen tekniikka

Identified topics

musculoskeletal diseases